| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
inquiry@bocsci.com |
|
| | Purine riboside-5'-O-triphosphate sodium salt Basic information |
| Product Name: | Purine riboside-5'-O-triphosphate sodium salt | | Synonyms: | PUTP SODIUM SALT;purineriboside-5’-o-triphosphate(putp),sodiumsalt;1-purin-9-yl-O5-(tetrahydroxy-[1]triphosphoryl)-β-D-1-deoxy-ribofuranose;Purine riboside triphosphate;Purine riboside-5'-triphosphate;PuTP;Purine riboside-5'-O-triphosphate sodium salt | | CAS: | 23197-96-8 | | MF: | C10H11N4Na4O13P3 | | MW: | 580.09 | | EINECS: | | | Product Categories: | | | Mol File: | 23197-96-8.mol |  |
| | Purine riboside-5'-O-triphosphate sodium salt Chemical Properties |
| | Purine riboside-5'-O-triphosphate sodium salt Usage And Synthesis |
| Uses | Purine riboside-5'-O-triphosphate, an active metabolite of Nebularine (HY-103694), acts as an inhibitor of DNA primase ATP and GTP polymerization activities, with IC50 values of 35 μM and 28 μM for the human enzyme, respectively. Purine riboside-5'-O-triphosphate also inhibits calmodulin-dependent protein kinase II (CaMKII) with a Ki value of 590 μM[1][2][3]. | | References | [1] Kozlowska M, et al. ATP depletion, purine riboside triphosphate accumulation and rat thymocyte death induced by purine riboside. Toxicol Lett. 1999;104(3):171-181. DOI:10.1016/s0378-4274(98)00369-5
[2] Moore CL, et al. Human DNA primase uses Watson-Crick hydrogen bonds to distinguish between correct and incorrect nucleoside triphosphates. Biochemistry. 2004;43(38):12367-12374. DOI:10.1021/bi0490791
[3] Kwiatkowski AP, et al. Mapping of the adenosine 5'-triphosphate binding site of type II calmodulin-dependent protein kinase. Biochemistry. 1987;26(24):7636-7640. DOI:10.1021/bi00398a016 |
| | Purine riboside-5'-O-triphosphate sodium salt Preparation Products And Raw materials |
|